The Inspirational Quest to Eradicate Cancer

The world-renowned Thoracic Oncologist, Dr. Gerold Bepler, joined I Don’t Care’s Kevin Stevenson for a conversation that was no less than inspirational. Dr. Bepler, President and CEO of the Karmanos Cancer Institute, has a mission; to eradicate cancer. It’s more than a dream for Dr. Bepler; he believes it will be a reality one day.

Dr. Bepler arrived from Germany to the United States in 1983. Following a post-doctoral fellowship at the National Cancer Institute, the starting point for his journey into lung cancer research. This career path took Dr. Bepler through many stops along the way, and in 2010 he joined the Karmanos Cancer Institute.

The mission to eradicate cancer got a boost in 1971 with the National Cancer Act, and Dr. Bepler said there’s tremendous progress towards this goal since that point. “People now diagnosed with cancer have hope,” Dr. Bepler said. “And many of them get cured of the disease and have a good quality of life. That all wouldn’t have been possible without the National Cancer Act.”

Much of the progress made to eradicating cancer at the Karmanos Cancer Institute owes a debt of gratitude to that 50-year-old law for providing necessary funding that makes such research possible.

“The Karmanos Cancer Institute became one of the NCI designated cancer centers,” Dr. Bepler said. “Very quickly, the National Cancer Institute realized just having one cancer institute in Bethesda, Maryland alone wouldn’t be able to achieve that high goal of eradicating cancer. This network established cancer centers throughout the United States.” What started as a couple of centers in the 1970s is now more than 50 comprehensive cancer centers.

The world now possesses many drugs and treatments to treat cancer through the dedication and research of institutes like the Karmanos Center. And some research led to treatments for other diseases. Dr. Bepler mentioned the Karmanos Center developed three of the first FDA-approved AIDS drugs.

More Like This Story:

The Rising Tide of Food Allergens

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Follow us on social media for the latest updates in B2B!

Image

Latest

Johnnie Akin
From Deloitte to Startup CEO: Johnnie Akin on Risk, Faith, and Reinvention
November 5, 2025

Success today looks different—defined less by stability and more by the freedom to adapt and evolve. Professionals across industries are reimagining their careers, moving away from predictable ladders toward paths that reflect purpose and balance. What once meant climbing steadily toward partnership or promotion now often means taking bold pivots or pursuing second acts…

Read More
caregiver
From Caregiver to Changemaker: How Purpose and Community Create Lasting Impact
November 5, 2025

Resilience isn’t just about enduring challenges — it’s about leading with compassion, patience, and faith, even when the path feels uncertain. It’s a quality embodied by every caregiver, whose daily acts of care and commitment reflect the essence of true leadership — helping others grow stronger through empathy, service, and understanding. In this episode…

Read More
leaders
Great Leaders Share Knowledge, Build Trust, and Empower Future Talent
November 3, 2025

The conversation around skilled trades is shifting fast. After decades of “college for all” messaging, trade school enrollment is climbing steadily, signaling a renewed respect for hands-on, high-skill careers that literally keep the world running. In commercial HVAC and mechanical service, this change is not just academic — it’s shaping the next generation of leaders…

Read More
NBA
Slow Stories in a Fast League: Why the NBA Still Deserves Real, In-Depth Journalism
November 3, 2025

In a sports world increasingly defined by short-form clips, social algorithms, and viral takes, long-form storytelling remains a vital counterweight — the place where depth, nuance, and narrative still matter. The NBA, perhaps more than any other league, sits at the center of this tension: every quote can become a meme, every story a highlight…

Read More